In the Commonwealth Fund’s To the Point blog, Sara Rosenbaum, the Harold and Jane Hirsh Professor of Health Law and Policy at the Milken Institute School of Public Health, makes a case for staving off harmful cuts to state Medicaid disproportionate share hospital (DSH) payments.
Why FDA Should Implement Some of the National Academies’ Recommendations for Making Medicines Affordable
As the National Academies of Sciences, Engineering, and Medicine points out in a recent report, Making Medicines Affordable: A National Imperative, the U.S. biopharmaceutical sector has been successful in developing and delivering effective drugs for improving health and fighting disease over the past decades. Many medical conditions that were long deemed untreatable can now be cured or managed effectively.
Trump Administration Contraceptive Rule Creates Problems for Both Women’s Health and Scientific Integrity
The Senate’s Tax Reform Bill Puts Public Health at Risk
In a sneak attack akin to Pearl Harbor, the Senate sought to deal a death blow to health insurance coverage under the Affordable Care Act by its last minute addition of the repeal of the individual responsibility mandate into its tax reform bill. The Congressional Budget Office estimated that this would lead health insurance coverage to fall by 13 million and to raise health insurance premiums by 10 percent. Combined with Pr